Page last updated: 2024-11-04

sulfinpyrazone and Adverse Drug Event

sulfinpyrazone has been researched along with Adverse Drug Event in 3 studies

Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pedersen, JM1
Matsson, P1
Bergström, CA1
Norinder, U1
Hoogstraate, J1
Artursson, P1
Liu, Z1
Shi, Q1
Ding, D1
Kelly, R1
Fang, H1
Tong, W1
Zhu, Z1
Puglisi, J1
Connors, D1
Stewart, J1
Herbst, J1
Marino, A1
Sinz, M1
O'Connell, J1
Banks, M1
Dickinson, K1
Cacace, A1

Other Studies

3 other studies available for sulfinpyrazone and Adverse Drug Event

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Bi

2008
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Da

2011
Use of cryopreserved transiently transfected cells in high-throughput pregnane X receptor transactivation assay.
    Journal of biomolecular screening, 2007, Volume: 12, Issue:2

    Topics: Biological Assay; Caco-2 Cells; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Membrane Permeabil

2007